CHICAGO - Lung cancer is responsible for approximately 1 in 4 cancer deaths in the United States, making it the deadliest ...

A new study led by researchers at Wake Forest University School of Medicine, in collaboration with the University of North ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back in the 1970s. Instead, fear of radiation, obsession with overdiagnosis, and ...

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...

There are only a few cancer diagnoses more terrifying than lung cancer. The disease is responsible for about one-third of all U.S. cancer deaths every year and only 15% of people diagnosed with it ...

In the study, less intensive follow-up was associated with a lower lung cancer risk through 1 and 2 years, "but this still could have led to delays in diagnosis and a reduction in the mortality ...

A strategy involving biennial screening at age 50, followed by annual screening at age 60, would result in a 20.6% reduction in the percentage of CT screenings performed. The strategy would mostly ...

Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic obstructive ...

INDIANAPOLIS — Lung cancer is the deadliest cancer in the United States. Every year, lung cancer claims more lives than breast, prostate and colon cancer combined. The reason is it so deadly? It often ...

Low-dose CT screening in a high-risk population detected lung cancer in 2.0% of participants, with nearly 80% of cases diagnosed at stage I or II. The screening protocol demonstrated 97.0% sensitivity ...

During this period of time, we (the family) went regularly for chest X-rays and some kind of test that involved a needle in ...

Real-world lung cancer screening populations are older and sicker than those in the National Lung Screening Trial. Older age and more comorbidities may reduce the benefits of lung cancer screening.